Literature DB >> 2113737

Diagnosis of primary cerebral lymphoma with particular reference to CT-guided stereotactic biopsy.

W Feiden1, K Bise, U Steude.   

Abstract

In establishing the histological diagnosis of primary cerebral lymphoma, stereotactic brain tumour biopsy is the method of choice as the mainstay of therapy is radiation and chemotherapy. This study describes the histopathology and diagnostic immunohistochemistry of 54 primary brain lymphomas in a mainly non-AIDS population. The stereotactic biopsies were performed using the Leksell CT stereotactic frame and a spiral needle which procured about 10-mm-long tissue cylinders. Usually, three successive biopsy cylinders were taken along the target trajectory. Histological examination revealed the prevalence of high-grade non-Hodgkin's lymphoma of the polymorphous centroblastic type. The series did not include any low-grade lymphomas or T-cell lymphomas. L-26 immunohistochemistry resulted in a positive staining of the blasts, thus confirming the B-cell origin of primary brain lymphomas. Small reactive T-lymphocytes and monohistiocytic cells were also found within and at the periphery of the lymphomas and in areas of degeneration. In the biopsies of nine patients, who had shown significant reduction of the lesions on the CT scans, after corticosteroid medication, regressive tissue changes were predominant and consisted of T-lymphocytes, macrophages, and occasionally bizarre reactive astrocytes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2113737     DOI: 10.1007/bf01600105

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  58 in total

1.  Utilization of monoclonal antibody L26 in the identification and confirmation of B-cell lymphomas. A sensitive and specific marker applicable to formalin-and B5-fixed, paraffin-embedded tissues.

Authors:  R W Cartun; F B Coles; W T Pastuszak
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

2.  Monoclonal antibody L26: an antibody that is reactive with normal and neoplastic B lymphocytes in routinely fixed and paraffin wax embedded tissues.

Authors:  A J Norton; P G Isaacson
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

3.  [Primary brain lymphomas. Anatomoclinical, ultrastructural and immunocytochemical study about 23 cases (author's transl)].

Authors:  J Hassoun; L Andrac; D Gambarelli; M Toga
Journal:  Ann Pathol       Date:  1981       Impact factor: 0.407

4.  Radiation therapy in the management of primary malignant lymphoma of the brain.

Authors:  M P Berry; W J Simpson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-01       Impact factor: 7.038

5.  A new instrument for stereotaxic brain tumour biopsy. Technical note.

Authors:  E O Backlund
Journal:  Acta Chir Scand       Date:  1971

6.  Paraffin section immunohistochemistry. I. Non-Hodgkin's lymphoma.

Authors:  P A Hall; A J d'Ardenne; A G Stansfeld
Journal:  Histopathology       Date:  1988-08       Impact factor: 5.087

7.  Primary central nervous system lymphoma in acquired immune deficiency syndrome: a clinical and pathological study.

Authors:  Y T So; J H Beckstead; R L Davis
Journal:  Ann Neurol       Date:  1986-11       Impact factor: 10.422

8.  Primary lymphoma of the central nervous system. Clinicopathological study of experience at Stanford.

Authors:  T L Helle; R H Britt; T V Colby
Journal:  J Neurosurg       Date:  1984-01       Impact factor: 5.115

9.  Primary lymphoma of the central nervous system.

Authors:  L Letendre; P M Banks; D F Reese; R H Miller; P W Scanlon; J M Kiely
Journal:  Cancer       Date:  1982-03-01       Impact factor: 6.860

10.  Developments in the diagnosis and treatment of primary CNS lymphoma. A prospective series.

Authors:  E A Neuwelt; E P Frenkel; M K Gumerlock; R Braziel; B Dana; S A Hill
Journal:  Cancer       Date:  1986-10-15       Impact factor: 6.860

View more
  11 in total

1.  Cerebellar T-cell lymphoma: an unusual primary intracranial neoplasm.

Authors:  J R Knorr; R L Ragland; B B Stone; B A Woda; N D Gelber
Journal:  Neuroradiology       Date:  1992       Impact factor: 2.804

2.  [Diagnosis of an initial infratentorial central nervous system B-cell lymphoma during prolonged cortisone medication].

Authors:  A Buss; A Assmus; J Weidemann; B Sellhaus; J Lorenzen; F Block
Journal:  Nervenarzt       Date:  2004-12       Impact factor: 1.214

3.  Accuracy of stereotactic brain tumor biopsy: comparison of the histologic findings in biopsy cylinders and resected tumor tissue.

Authors:  W Feiden; U Steude; K Bise; O Gündisch
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

4.  Primary T-cell lymphoma of the brain in acquired immunodeficiency syndrome: case report.

Authors:  A K Bindal; K S Blisard; H Melin-Aldama; R E Warnick
Journal:  J Neurooncol       Date:  1997-02       Impact factor: 4.130

Review 5.  Primary cerebral malignant non-Hodgkin's lymphomas: a retrospective clinical study.

Authors:  D F Braus; K Schwechheimer; H K Müller-Hermelink; G Schwarzkopf; B Volk; F Mundinger
Journal:  J Neurol       Date:  1992-03       Impact factor: 4.849

6.  A new xenograft model of primary central nervous system lymphoma.

Authors:  M Saini; M Bellinzona; W Weichhold; M Samii
Journal:  J Neurooncol       Date:  1999-06       Impact factor: 4.130

Review 7.  Primary central nervous system lymphoma.

Authors:  W S Velasquez
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

8.  CT-guided and computer assisted stereotactic biopsy. Technique, results, indications.

Authors:  J Voges; R Schröder; H Treuer; O Pastyr; W Schlegel; W J Lorenz; V Sturm
Journal:  Acta Neurochir (Wien)       Date:  1993       Impact factor: 2.216

Review 9.  Primary central nervous system lymphomas--an update.

Authors:  K A Jellinger; W Paulus
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

10.  Occult systemic non-Hodgkin's lymphoma (NHL) in patients initially diagnosed as primary central nervous system lymphoma (PCNSL): how much staging is enough?

Authors:  B P O'Neill; R P Dinapoli; P J Kurtin; T M Habermann
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.